Skip to main content
Clinical Trials/NL-OMON45439
NL-OMON45439
Completed
Not Applicable

Study on the relationship between genes and disease severity, disease burden and effectiveness of disease modifying medication in Dutch patients with Multiple Sclerosis - GEMS study - Genetic Etiology of Multiple Sclerosis

Drug Target ID, Ltd.0 sites600 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
demyelinating disease
Sponsor
Drug Target ID, Ltd.
Enrollment
600
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Drug Target ID, Ltd.

Eligibility Criteria

Inclusion Criteria

  • 600 Dutch patients with MS from six MS centres. We estimate that approximately 100 patients per centre will participate in the study, which is a feasible number of patients according to the neurologists of the respective centres.;In order to be eligible to participate in this study, subjects must meet all of the following criteria:
  • \- diagnosed with MS for at least one year
  • \- able and willing to participate in the study
  • \- Dutch and from caucasian origin
  • \- between 20 and 60 years of age;In addition, we are aiming for the gender distribution of our subjects to reflect the epidemiological findings for MS, i.e. approximately 35 % male and 65 % female subjects.

Exclusion Criteria

  • Not applicable.

Outcomes

Primary Outcomes

Not specified

Similar Trials